Crnovrsanin, Nerma
Zumsande, Sarah
Rompen, Ingmar Florin
Schiefer, Sabine
Zimmer, Sarah
Hu, Wenjun
Arnscheidt, Johanna
Brinkmann, Fritz
Longerich, Thomas
Haag, Georg Martin
Schmidt, Thomas
Al-Saeedi, Mohammed
Sisic, Leila
Nienhüser, Henrik
Funding for this research was provided by:
Heidelberger Stiftung Chirurgie
Universitätsklinikum Heidelberg
Article History
Received: 26 September 2024
Accepted: 11 March 2025
First Online: 25 March 2025
Disclosures
: Georg Martin Haag reports a consulting or advisory role for Bristol-Myers Squibb; MSD Sharp & Dohme; Lilly; Daiichi Sankyo, Servier; Pierre Fabre; Astra Zeneca; Abbvie; Beigene; receipt of honoraria from Servier; MSD Sharp & Dohme; Lilly; Bristol-Myers Squibb; Astra Zeneca; Swiss cancer League, Astellas; Beigene; Deciphera;Streamed-up; receipt of research funding from DKFZ Heidelberg, MSD Sharp & Dohme; and receipt of travel and accommodations from Bristol-Myers Squibb; Lilly; Servier; MSD Sharp & Dohme, Daiichi Sankyo. Nerma Crnovrsanin, Sarah Zumsande, Ingmar F. Rompen, Sabine Schiefer, Sarah Zimmer, Wenjun Hu, Johanna Arnscheidt, Fritz Brinkmann, Thomas Longerich, Thomas Schmidt, Mohammed Al-Saeedi, Leila Sisic, and Henrik Nienhüser report no conflicts of interest that may be relevant to the contents of this study.